TARO-PALBOCICLIB
Analogs of TARO-PALBOCICLIB
Find cheaper analogs and generic equivalents for TARO-PALBOCICLIB.
Active Ingredient: PALBOCICLIB
Product Overview
About TARO-PALBOCICLIB
TARO-PALBOCICLIB is a prescription medication containing the active ingredient Palbociclib. It is a selective inhibitor of cyclin-dependent kinases (CDKs) 4 and 6, which play a crucial role in cell cycle progression.
Key Benefits & Uses
- Treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women.
- Treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer in women with disease progression on or after prior therapy directed at the estrogen receptor (ER) and/or human epidermal growth factor receptor 2 (HER2) of the breast.
Active Ingredient & Action
Palbociclib works by inhibiting the activity of CDK4 and CDK6, which are enzymes that help drive cell division. By blocking these enzymes, Palbociclib slows down the growth and spread of cancer cells, allowing the body's immune system to attack and destroy them.
Important Notes
TARO-PALBOCICLIB is available only by prescription and should be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of adverse effects. Patients should be monitored regularly for signs of neutropenia, anemia, and other potential side effects.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.